Detalhe da pesquisa
1.
Targeting PP2A-dependent autophagy enhances sensitivity to ruxolitinib in JAK2V617F myeloproliferative neoplasms.
Blood Cancer J
; 13(1): 106, 2023 07 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37423955
2.
Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold.
Cancer Res
; 83(15): 2461-2470, 2023 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37272750
3.
CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia.
Cancer Res
; 83(17): 2824-2838, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37327406
4.
C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant Leukemia.
Cancer Discov
; 13(7): 1720-1747, 2023 07 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37012202
5.
Improving the Quality of EDTA-treated Blood Specimens from Mice.
J Am Assoc Lab Anim Sci
; 61(2): 188-194, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35022109
6.
AMPK-PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemia.
Cell Rep
; 38(1): 110197, 2022 01 04.
Artigo
Inglês
| MEDLINE | ID: mdl-34986346
7.
RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia.
Leukemia
; 36(5): 1237-1252, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35354920
8.
Disrupting Mitochondrial Electron Transfer Chain Complex I Decreases Immune Checkpoints in Murine and Human Acute Myeloid Leukemic Cells.
Cancers (Basel)
; 13(14)2021 Jul 13.
Artigo
Inglês
| MEDLINE | ID: mdl-34298712
9.
Adrenomedullin-CALCRL axis controls relapse-initiating drug tolerant acute myeloid leukemia cells.
Nat Commun
; 12(1): 422, 2021 01 18.
Artigo
Inglês
| MEDLINE | ID: mdl-33462236
10.
Activation of Vitamin D Receptor Pathway Enhances Differentiating Capacity in Acute Myeloid Leukemia with Isocitrate Dehydrogenase Mutations.
Cancers (Basel)
; 13(20)2021 Oct 19.
Artigo
Inglês
| MEDLINE | ID: mdl-34680392
11.
Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia.
J Exp Med
; 218(5)2021 05 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33760042
12.
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia.
Nat Cancer
; 2(11): 1204-1223, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35122057